Nomenclature of Biotechnologically Derived Pharmaceutical Substances — A View from Japan

  • Takao Hayakawa
Conference paper

Abstract

Some aspects regarding Japanese Accepted Names (JAN) for biotechnologically-derived pharmaceutical substances are described from the point of view of a regulatory scientist who is engaged in the quality control of these types of drugs, as well as from the viewpoint of a biochemist.

Keywords

Carbohydrate Codon Marketing Polypeptide Interferon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kaplan SL et al; Bierich JR (1986) In: Raiti S, Tolman RA (eds) Growth hormone. Plenum Medical, New York LondonGoogle Scholar
  2. 2.
    Kikumoto Y et al (1987) Biochem Biophys Res Commun 147:315CrossRefGoogle Scholar
  3. 3a.
    Kasai S et al (1985) J Biol Chem 260:12377Google Scholar
  4. 3b.
    Kasai S et al (1985) J. Biol Chem 260:12382Google Scholar
  5. 4.
    Kasai S et al (1985) Cell Struc Func 10:151CrossRefGoogle Scholar
  6. 5.
    Rademacher TW et al (1988) Ann Rev Biochem 57:785CrossRefGoogle Scholar
  7. 6.
    Knight P (1989) Bio/Technology 7:35CrossRefGoogle Scholar
  8. 7a.
    Moyle WR et al (1975) J Biol Chem 250:9163;Google Scholar
  9. 7b.
    Goverman JM et al (1982) J Biol Chem 257:15059Google Scholar
  10. 8a.
    Nishimura R et al (1981) J Endocrinol Invest 4:349;Google Scholar
  11. 8b.
    Mizuochi T et al (1983) J Biol Chem 258:14126Google Scholar
  12. 9.
    Sairam MR, Bhargavi GN (1985) Science 229:65CrossRefGoogle Scholar
  13. 10.
    Berman MI et al (1985) Biochem Biophys Res Commun 133:680CrossRefGoogle Scholar
  14. 11.
    Matzuk MM et al (1989) J Biol Chem 264:2409Google Scholar
  15. 12.
    Wittwer AJ et al (1989) Biochemistry 28:7662CrossRefGoogle Scholar
  16. 13.
    Parekh RB et al (1989) Biochemistry 28:7670CrossRefGoogle Scholar
  17. 14.
    Goldwasser E et al (1974) J Biol Chem 249:4202Google Scholar
  18. 15.
    Ochi N et al (1987) Exp Hematology 15:556Google Scholar
  19. 16.
    Goto M et al (1988) Bio/Technology 6:67CrossRefGoogle Scholar
  20. 17.
    Takeuchi M et al (1989) Proc Natl Acad Sci USA 86:7819CrossRefGoogle Scholar
  21. 18.
    Parekh RB et al (1989) Biochemistry 28:7644CrossRefGoogle Scholar
  22. 19.
    Baenziger JU, Green ED (1988) Biochim Biophys Acta 947:287Google Scholar
  23. 20.
    Kagawa Y et al (1988) J Biol Chem 263:17508Google Scholar
  24. 21.
    Tsuda E et al (1988) Biochemistry 27:5646CrossRefGoogle Scholar
  25. 22.
    Sasaki H et al (1987) J Biol Chem 262:12059Google Scholar
  26. 23.
    Takeuchi M et al (1988) J Biol Chem 263:3657Google Scholar
  27. 24.
    Ohkura T et al (1984) Biochemistry 24:503CrossRefGoogle Scholar
  28. 25.
    Opdenakker G et al (1988) FEBS Letter 238:129CrossRefGoogle Scholar
  29. 26.
    Rothman RJ et al (1989) Biochemistry 28:1377CrossRefGoogle Scholar
  30. 27.
    Lustbader J et al (1987) J Biol Chem 262:14204Google Scholar
  31. 28.
    Morell AG et al (1971) J Biol Chem 246:1461Google Scholar
  32. 29.
    Donahue RE et al (1986) Cold Spring Harbor Symposia Quant Biol 51 :685Google Scholar
  33. 30.
    Lucore CL et al (1988) Circulation 77:906CrossRefGoogle Scholar
  34. 31.
    Collen D et al (1988) Blood 71:216Google Scholar
  35. 32.
    Kinoshita H et al (1989) In: Marshak DR, Liu DT (eds) Current Commun Mol Biol (Formulation, Delivery, Targetinq). Cold Spring Harbor Lab, New YorkGoogle Scholar
  36. 33.
    Dahl KD et al (1988) Science 239:72CrossRefGoogle Scholar
  37. 34.
    Suzuki K et al (1985) Chem Pharm Bull (Tokyo) 33:886CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • Takao Hayakawa
    • 1
  1. 1.National Institute of Hygienic SciencesSetagaya-Ku, Tokyo 158Japan

Personalised recommendations